Back to Search Start Over

Rapid ventricular tachycardia in patients with tetralogy of Fallot and implantable cardioverter-defibrillator: Insights from the DAI-T4F nationwide registry

Authors :
Mikael Laredo
Guillaume Duthoit
Frédéric Sacher
Frédéric Anselme
Caroline Audinet
Francis Bessière
Pierre Bordachar
Abdeslam Bouzeman
Serge Boveda
Sok Sithikun Bun
Morgane Chassignolle
Gaël Clerici
Antoine Da Costa
Maxime de Guillebon
Pascal Defaye
Nathalie Elbaz
Romain Eschalier
Fabrice Extramiana
Laurent Fauchier
Alexis Hermida
Estelle Gandjbakhch
Rodrigue Garcia
Jean-Baptiste Gourraud
Charles Guenancia
Benoit Guy-Moyat
Didier Irles
Laurence Iserin
François Jourda
Linda Koutbi
Fabien Labombarda
Magalie Ladouceur
Philippe Lagrange
Nicolas Lellouche
Jacques Mansourati
Christelle Marquié
Raphael Martins
Grégoire Massoulié
Amel Mathiron
Philippe Maury
Anne Messali
Antoine Milhem
Pierre Mondoly
Cédric Nguyen
Sandro Ninni
Jean Luc Pasquié
Bertrand Pierre
Penelope Pujadas
Jean-Marc Sellal
Jean-Benoit Thambo
Camille Walton
Pierre Winum
Cyril Zakine
Alexandre Zhao
Xavier Jouven
Nicolas Combes
Eloi Marijon
Victor Waldmann
CHU Pitié-Salpêtrière [AP-HP]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
IHU-LIRYC
Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]
Institut de rythmologie et modélisation cardiaque [Pessac] (IHU Liryc)
Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP]
CHU Pontchaillou [Rennes]
Laboratoire Traitement du Signal et de l'Image (LTSI)
Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] (PhyMedExp)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier)
Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970))
Hôpital Européen Georges Pompidou [APHP] (HEGP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)
Source :
Heart Rhythm, Heart Rhythm, 2022, 20 (2), pp.252-260. ⟨10.1016/j.hrthm.2022.10.016⟩
Publication Year :
2023
Publisher :
Elsevier BV, 2023.

Abstract

In repaired tetralogy of Fallot (TOF), little is known about characteristics of patients with rapid ventricular tachycardia (VT). Also, whether patients with a first episode of nonrapid VT may subsequently develop rapid VT or ventricular fibrillation (VF) has not been addressed.The objectives of this study were to compare patients with rapid VT/VF with those with nonrapid VT and to assess the evolution of VT cycle lengths (VTCLs) overtime.Data were analyzed from a nationwide registry including all patients with TOF and implantable cardioverter-defibrillator (ICD) since 2000. Patients with ≥1 VT episode with VTCL ≤250 ms (240 beats/min) formed the rapid VT/VF group.Of 144 patients (mean age 42.0 ± 12.7 years; 104 [72%] men), 61 (42%) had at least 1 VT/VF episode, including 28 patients with rapid VT/VF (46%), during a median follow-up of 6.3 years (interquartile range 2.2-10.3 years). Compared with patients in the nonrapid VT group, those in the rapid VT/VF group were significantly younger at ICD implantation (35.2 ± 12.6 years vs 41.5 ± 11.2 years; P = .04), had more frequently a history of cardiac arrest (8 [29%] vs 2 [6%]; P = .02), less frequently a history of atrial arrhythmia (11 [42%] vs 22 [69%]; P = .004), and higher right ventricular ejection fraction (43.3% ± 10.3% vs 36.6% ± 11.2%; P = .04). The median VTCL of VT/VF episodes was 325 ms (interquartile range 235-429 ms). None of the patients with a first documented nonrapid VT episode had rapid VT/VF during follow-up.Patients with TOF and rapid VT/VF had distinct clinical characteristics. The relatively low variation of VTCL over time suggests a room for catheter ablation without a backup ICD in selected patients with well-tolerated VT.Clinicaltrials.gov identifier: NCT03837574.

Details

ISSN :
15475271 and 15563871
Volume :
20
Database :
OpenAIRE
Journal :
Heart Rhythm
Accession number :
edsair.doi.dedup.....ec63ac892960527ef3f3f3afea50427c
Full Text :
https://doi.org/10.1016/j.hrthm.2022.10.016